Wipro, Zomato, Vodafone Idea, PNB, Yes Bank, Dish TV, Cadila Healthcare at a glance


BSE Sensex and Nifty 50 were expected to start late today. (Photo: REUTERS)

Clever futures extended losses and were now trading at 162 points, down 0.92% to 17,439.50 on the Singapore Stock Exchange. BSE Sensex and Nifty 50 were expected to start late today. Analysts say building a “bad bank” is a positive development as the focus remains on resolving stressed assets faster, which will improve banks’ balance sheets. “Valuations are not comfortable and could therefore lead to episodes of profit reservation. Weak global signals due to concern over slowing economic growth and increasing cases of Delta variants around the world would make a market swing between greed and fear, ”said Siddhartha Khemka, head of retail research, Motilal Oswal Financial Services.

Actions to watch

Wipro: Wipro announced the launch of the Wipro-Google Cloud Innovation Arena in Bangalore to accelerate the adoption of cloud services.

Vodafone idea: The telecommunications company informed that its 26th annual general meeting (AGM) will be held on Wednesday, September 29, 2021. In addition, the company claimed to have recorded a top speed of 3.7 gigabits per second (gbps), the highest of all operators in India, during 5G trials in Pune. The company also claimed to have recorded a download speed of 1.5 Gbps in the medium band spectrum in Gandhinagar and Pune.

Zomato: Online food delivery platform Zomato said on Saturday it had not disclosed the exit of its co-founder, Gaurav Gupta, to the exchanges because he was not named as a key management staff, nor a promoter. of the company. Responding to a clarification requested by the ESB, Zomato said in a regulatory filing: “… we would like to submit that Mr. Gaurav Gupta is not designated as key management personnel under the Companies Act 2013 and of the List Regulation “.

Satellite TV, Yes Bank: Direct broadcast service provider Dish TV, which faces special notice from shareholder Yes Bank to dismiss CEO Jawahar Goel and four other directors, has requested an extension of the deadline for holding the general meeting annual of the company.

Cadila Health: Zydus Cadila has received final approval from the USFDA to market vortioxetine tablets in strengths of 5 mg, 10 mg, 20 mg. Vortioxetine is used to treat depression. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Vortioxetine is an SSRI (Selective Serotonin Reuptake Inhibitor) and a serotonin receptor modulator. The drug will be manufactured at the group’s formulation manufacturing plant in the SEZ in Ahmedabad.

Get live stock quotes for BSE, NSE, US market and latest net asset value, mutual fund portfolio, see the latest IPO news, top IPOs, calculate your tax Using the income tax calculator, know the best winners, the best losers and the best equity funds in the market. Like us on Facebook and follow us on Twitter.

ALSO READ  F&O Expiration Outlook October 28: Clever support at 18060-18000; Bank Nifty will guide Nifty 50 this expiration week

The Bharat Express News is now on Telegram. Click here to join our channel and stay up to date with the latest news and updates from Biz.